CSBR Insider Trading Activity and SEC Form 4 Filings
CSBR insider trading summary
No open-market insider purchases or sales of Champions Oncology, Inc. (CSBR) have been reported on SEC Form 4 in the past 12 months.
Latest CSBR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 12, 2024 | Daniel Newman Mendelson | Director | Buy | $7K (1,000 @ $6.50) |
| Jan 11, 2024 | Daniel Newman Mendelson | Director | Buy | $13K (2,000 @ $6.27) |
| Jan 10, 2024 | Daniel Newman Mendelson | Director | Buy | $19K (2,944 @ $6.31) |
| Jan 9, 2024 | Daniel Newman Mendelson | Director | Buy | $19K (3,000 @ $6.25) |
| Jan 8, 2024 | Daniel Newman Mendelson | Director | Buy | $6K (1,000 @ $6.15) |
| Jan 5, 2024 | Daniel Newman Mendelson | Director | Buy | $12K (2,000 @ $6.09) |
| Jan 4, 2024 | Daniel Newman Mendelson | Director | Buy | $18K (3,000 @ $6.12) |
| Jan 3, 2024 | Daniel Newman Mendelson | Director | Buy | $3K (500 @ $5.83) |
| Dec 21, 2023 | Daniel Newman Mendelson | Director | Buy | $12K (2,500 @ $4.92) |
| Dec 20, 2023 | Daniel Newman Mendelson | Director | Buy | $10K (2,100 @ $4.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.